certolizumab
ucb pharmaceuticals
['certolizumab', 'axspa']
0543. exploratory analysis of potential disconnect between objective inflammatory response &amp; clinical response following certolizumab pegol in axspa martin rudwaleit
12s142. abstract session: spa trt i
#acr22 #acrambassador
#rheumtwitter #medtwitter #spondyloarthritis 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books